Module 1 - Understanding Biologics and Biosimilars
1 Biologic medications
2 Biosimilar medications
3 Producing biologic and biosimilar medications
4 Inherent variability
5 Comparability
Learning Objectives:
1. Describe biologic medications, including how they are made and how they are used in clinical practice
2. Describe biosimilar medications including how they differ from biologics and other generic medications and why they are used in clinical practice
3. Compare and contrast biologic and biosimilar medications
Module 2 - Regulatory Approval Process
1 Regulatory Approval of Biosimilars
2 Drug Indications
Learning Objectives:
1. Describe the approval process for biosimilars in Canada
2. Describe situations where biosimilars may and may not be used in place of biologics
Module 3 - Patient Access
1 Biosimilar use in clinical practice
2 Access and coordination of care
Learning Objectives:
1. List the advantages and disadvantages of biosimilars in clinical practice
2. Describe Patient Support Programs (PSP) and their role in helping patients coordinate cost and administration (injecting) biosimilars
3. Describe how biosimilars are funded in Canada
Module 4 - Discussing Biosimilars with your HCP
1 Monitoring
2 Communicating with your healthcare provider
Learning Objectives:
1. List common questions you should ask your healthcare providers (doctors, nurses and pharmacists) about biosimilars
2. Describe how biosimilar use is monitored in Canada with respect to side effects and adverse drug reactions
Additional Course Resources
- Currently marketed biosimilars and their reference biologics (link to Health Canada drug database)
- pCOBI infographics/brochures
- Videos/blogs (ex. From patient reps)
- Links to provincial / territorial resources
- Links to additional resources